文献速递消化道肿瘤与早癌消化内镜

监测性结肠镜对Lynch综合征患者结直肠癌发病与死亡的影响:英国NHS 2010-2022年全国观察性队列研究

Impact of surveillance colonoscopy on colorectal cancer incidence and mortality in Lynch syndrome: a national observational cohort study of patients in the English NHS 2010-2022.
PubMed 文献 · Gut · 2026-08-06

该研究基于英国NHS关联登记数据,纳入4732例MMR基因携带者,评估结肠镜监测依从性及其对结直肠癌发病与死亡的影响。平均间隔≤3年的监测与结直肠癌特异性死亡和全因死亡下降相关,但总体结直肠癌发病率无变化;平均间隔≤2年的监测与总体结直肠癌发病率升高相关。

要点

  • 平均间隔≤3年的结肠镜监测与结直肠癌特异性死亡及全因死亡下降相关
  • 平均间隔≤3年的监测未改变总体结直肠癌发病率,未见明确分期迁移
  • 平均间隔≤2年的监测与总体及早期结直肠癌发病率升高相关,需警惕过度诊断

核心结论

  • 规律监测的MMR携带者全因死亡下降,可能反映监测对结直肠癌特异性死亡的影响,但非随机设计下也可能反映选择偏倚。

研究设计与样本

  • 基于英国NHS数字记录关联的Lynch综合征患者登记队列,纳入4732例MMR基因携带者,描述结肠镜检查频率并用逻辑回归分析监测依从性的预测因素。
  • 对有监测记录和无监测记录的MMR携带者,估计年龄别年结直肠癌发病率(AS-AIRs)和累积终生风险,比较结直肠癌分期分布和分期特异性AS-AIRs以评估分期迁移,并用Kaplan-Meier法和Cox比例风险回归估计结直肠癌死亡和全因死亡风险。

主要发现

  • 平均间隔≤3年的监测(n=3028)与结直肠癌特异性死亡和全因死亡下降相关,即使多因素调整后总体结直肠癌发病率也无变化。
  • 未观察到明确的分期迁移证据。
  • 平均间隔≤2年的结肠镜监测(n=1569)与总体结直肠癌发病率升高相关,早期癌症发病率也更高,而晚期癌症无相应下降。

关键数值与推荐

  • 平均监测间隔≤3年组n=3028,与结直肠癌特异性死亡和全因死亡下降相关,总体结直肠癌发病率无变化。
  • 平均监测间隔≤2年组n=1569,与总体结直肠癌发病率升高相关,早期癌症发病率更高而晚期癌症无相应下降。

临床怎么用

  • 对MMR基因携带者,平均间隔≤3年的结肠镜监测与死亡风险下降相关,支持遵循国家监测指南。
  • 平均间隔≤2年的监测与总体及早期结直肠癌发病率升高相关,临床需权衡监测频率与过度诊断风险。

局限性

  • 非随机研究设计,规律监测者全因死亡下降可能反映选择偏倚。
  • 平均间隔≤2年监测组早期癌症发病率升高而晚期无相应下降,可能反映随访时间短、频谱偏倚或过度诊断的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lynch syndrome (LS) is a cancer susceptibility syndrome caused by germline pathogenic variants in DNA mismatch repair (MMR) genes. Due to increased risk of colorectal cancer (CRC), enhanced colonoscopic surveillance is recommended for heterozygote MMR carriers. OBJECTIVE: Using a registry of English patients with LS linked to digital National Health Service records, we aimed to assess adherence of MMR carriers to national surveillance guidelines and to determine the impact of surveillance on CRC incidence and mortality. DESIGN: We described the frequency of colonoscopies in 4732 MMR carriers and used logistic regression to determine predictors of surveillance adherence. For MMR carriers with a record of surveillance and those without, we estimated age-specific annual CRC incidence rates (AS-AIRs) and cumulative lifetime risks; assessed for stage shift by comparing CRC stage distributions and stage-specific AS-AIRs; and estimated risks of death from CRC and any cause using Kaplan-Meier methods and Cox proportional hazards regression. RESULTS: Surveillance at a mean interval of ≤3 years (n=3028) was associated with a decrease in CRC-specific and all-cause mortality, without an associated change in total CRC incidence, even after multivariate adjustment. No strong evidence of stage shift was observed. Colonoscopic surveillance at a mean interval of ≤2 years (n=1569) was associated with an increase in total CRC incidence. Incidence of early-stage cancers was also higher, with no corresponding decrease in late-stage cancers, which may reflect the short follow-up period, spectrum bias, or the impact of overdiagnosis. CONCLUSION: The observed reduction in all-cause mortality among regularly surveilled MMR carriers may indicate an impact of surveillance on CRC-specific mortality, though in the context of a non-randomised study could also reflect the influence of selection bias.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Huntley C, Loong L, Mallinson C, et al. Impact of surveillance colonoscopy on colorectal cancer incidence and mortality in Lynch syndrome: a national observational cohort study of patients in the English NHS 2010-2022. Gut. 2026. PMID: 42562418. doi:10.1136/gutjnl-2025-337379

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。